Korro Bio, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-42.2M | $79.6M |
| FY2022 | — | $-99.0M | $36.3M |
| FY2023 | — | $169.9M | $36.6M |
| FY2024 | — | $160.4M | $55.6M |
| FY2025 | — | $51.4M | $21.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-42.2M | $79.6M |
| FY2022 | — | $-99.0M | $36.3M |
| FY2023 | — | $169.9M | $36.6M |
| FY2024 | — | $160.4M | $55.6M |
| FY2025 | — | $51.4M | $21.8M |